|
Investors - Business Summary
Arrayit Corporation (ARYC) is a new public company dedicated to increasing the quality, access and affordability of health care by providing innovative geneomics and proteomics products and services for the life sciences, diagnostics, pharmaceutical and personalized medicine marketplaces. Arrayit’s business summary is provided herein.
Business Summary
Arrayit Corporation develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics.
Forward Looking Statements
Some information contained in or incorporated by reference into this website are “forward looking statements” within the meaning of the United States private securities litigation reform act of 1995. All forward-looking statements involve risks and uncertainties. In particular, any statements regarding pro-forma finances, future sales, results of operations, operating efficiencies and product expansion are subject to known and unknown risks, uncertainties and contingencies. Many of these risks, uncertainties and contingencies are beyond the control of the company and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. Accordingly, you should not place undue reliance on the forward-looking statements contained in this website. These forward-looking statements speak only as of the date on which the statements were made. In evaluating forward-looking statements, you should consider these risks and uncertainties. The company does not assume any obligation to update any such forward-looking statements to reflect events or circumstances after the date of posting of this information.
Copyright 1993-2010 Arrayit Corporation. All rights reserved.
|
